Abstract
Cellulose is a naturally existing element in the plant’s cell wall and in several bacteria. The unique characteristics of bacterial cellulose (BC), such as non-toxicity, biodegradability, hydrophilicity, and biocompatibility, together with the modifiable form of nanocellulose, or the integration with nanoparticles, such as nanosilver (AgNP), all for antibacterial effects, contributes to the extensive usage of BC in wound healing applications. Due to this, BC has gained much demand and attention for therapeutical usage over time, especially in the pharmaceutical industry when compared to plant cellulose (PC). This paper reviews the progress of related research based on in vitro, in vivo, and clinical trials, including the overall information concerning BC and PC production and its mechanisms in wound healing. The physicochemical differences between BC and PC have been clearly summarized in a comparison table. Meanwhile, the latest Food and Drug Administration (FDA) approved BC products in the biomedical field are thoroughly discussed with their applications. The paper concludes on the need for further investigations of BC in the future, in an attempt to make BC an essential wound dressing that has the ability to be marketable in the global marketplace.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference126 articles.
1. Cellulose Fiber Market Size, Share & Trends Analysis by Product Type (Natural, Synthetic), By Application (Textile, Hygiene, Industrial), By Regions And Segment Forecasts, 2018—2025,2016
2. Biopolymers;Rudin,2013
3. An Update on Overview of Cellulose, Its Structure and Applications
4. Cellulose,2020
5. Sources of cellulose and their applications—A review;Lavanya;Int. J. Drug Formul. Res.,2011
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献